Style | Citing Format |
---|---|
MLA | Taymouri S, et al.. "In-Vitro and In-Vivo Evaluation of Chitosanbased Thermosensitive Gel Containing Lorazepam Nlcs for the Treatment of Status Epilepticus." IET Nanobiotechnology, vol. 14, no. 2, 2020, pp. 148-154. |
APA | Taymouri S, Minaiyan M, Ebrahimi F, Tavakoli N (2020). In-Vitro and In-Vivo Evaluation of Chitosanbased Thermosensitive Gel Containing Lorazepam Nlcs for the Treatment of Status Epilepticus. IET Nanobiotechnology, 14(2), 148-154. |
Chicago | Taymouri S, Minaiyan M, Ebrahimi F, Tavakoli N. "In-Vitro and In-Vivo Evaluation of Chitosanbased Thermosensitive Gel Containing Lorazepam Nlcs for the Treatment of Status Epilepticus." IET Nanobiotechnology 14, no. 2 (2020): 148-154. |
Harvard | Taymouri S et al. (2020) 'In-Vitro and In-Vivo Evaluation of Chitosanbased Thermosensitive Gel Containing Lorazepam Nlcs for the Treatment of Status Epilepticus', IET Nanobiotechnology, 14(2), pp. 148-154. |
Vancouver | Taymouri S, Minaiyan M, Ebrahimi F, Tavakoli N. In-Vitro and In-Vivo Evaluation of Chitosanbased Thermosensitive Gel Containing Lorazepam Nlcs for the Treatment of Status Epilepticus. IET Nanobiotechnology. 2020;14(2):148-154. |
BibTex | @article{ author = {Taymouri S and Minaiyan M and Ebrahimi F and Tavakoli N}, title = {In-Vitro and In-Vivo Evaluation of Chitosanbased Thermosensitive Gel Containing Lorazepam Nlcs for the Treatment of Status Epilepticus}, journal = {IET Nanobiotechnology}, volume = {14}, number = {2}, pages = {148-154}, year = {2020} } |
RIS | TY - JOUR AU - Taymouri S AU - Minaiyan M AU - Ebrahimi F AU - Tavakoli N TI - In-Vitro and In-Vivo Evaluation of Chitosanbased Thermosensitive Gel Containing Lorazepam Nlcs for the Treatment of Status Epilepticus JO - IET Nanobiotechnology VL - 14 IS - 2 SP - 148 EP - 154 PY - 2020 ER - |